In his first address to a joint session of Congress April 28, President Joe Biden made a pitch for significantly increasing federal funding for biomedical research, especially cancer research—a cornerstone of his jobs plan.
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).
